Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode

NCT05384392 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT05384392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05384392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode
Lead sponsor
University Hospital, Brest
Phase
Not applicable
Overall status
Recruiting
Start date
March 27, 2025
Completion date
March 31, 2030
Enrollment
217 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

first-episode psychosis